Prove-it Sepsis Highly Acknowledged in The Lancet!

The most respected medical journal, The Lancet, is publishing the results of the clinical study conducted with the Prove-it Sepsis assay, first online (www.thelancet.com) and in the upcoming edition, written by Dr Vanya Gant (UK) and Dr Päivi Tissari (Finland) and colleagues.

The authors conclude that the identification of sepsis-causing bacteria using a new microarray platform is highly accurate and delivers results an average of 18 hours faster than the conventional culture-based system.

In the accompanying comments, Dr Shin Lin (USA) and Dr Samuel Yang (USA) consider Prove-it Sepsis  as a major advance in sepsis diagnostics, and continue "By combining elements of molecular biology and standard culture-based methods, the Prove-it Sepsis brings together the best of both worlds."

Read the whole story here.